Various methods for determining whether a subject has alcoholic hepatitis are described. In one aspect, a method for determining whether a subject has alcoholic hepatitis is described. The method includes determining the levels of a trimethylamine in a biological sample obtained from the subject. The level of trimethylamine in the biological sample is compared to the control value, and the subject whose level of trimethylamine exceeds the control value is diagnosed as having alcoholic hepatitis. In another aspect of the present invention a method for assessing a subject as having alcoholic hepatitis (AH) includes determining the level of trimethylamine and the level of pentane in a biological sample obtained from the subject. A TAP score is determined based on the concentration of trimethylamine and the concentration of pentane. The subject is diagnosed as having alcoholic hepatitis if the TAP score exceeds a control value.
申请公布号
WO2016115027(A1)
申请公布日期
2016.07.21
申请号
WO2016US12825
申请日期
2016.01.11
申请人
THE CLEVELAND CLINIC FOUNDATION
发明人
DWEIK, RAED;HANOUNEH, IBRAHIM;ZEIN, NIZAR N.;GROVE, DAVID;CIKACH, FRANK, S., JR.